Open access · CC-BY
via OpenAlex
Mitochondrial Dysfunction and Bioenergetics in Chronic Obstructive Pulmonary Disease: Mechanisms, Biomarkers, and Therapeutic Opportunities
Rishit Bhat, Liam B. Dunne, Sophia Miles, Ahmad Kazi, Daniyal Siddiqui, Mutahhar N. Warriach, Chibudom T. Ofoegbu, Zaid Vellani
The Yale Journal of Biology and Medicine · 2026
Mitochondrial dysfunction
Altered intercellular communication
Chronic inflammation
Metformin
Human
Review
Abstract
Chronic obstructive pulmonary disease (COPD) is a heterogeneous lung condition characterized by chronic respiratory symptoms and persistent obstruction of airflow arising from abnormalities of the airways and/or alveoli. Its pathogenesis includes multiple interacting exposures and susceptibilities, including cigarette smoking, biomass and occupational exposures, air pollution, and genetic factors. Per this paradigm, researchers have historically focused on developing broad anti-inflammatory therapeutics that manage acute symptoms but fail to arrest progressive decline. Within this heterogeneous disease framework, mitochondrial dysfunction(definition) may contribute to chronic obstructive pulmonary disease pathobiology through interactions with oxidative stress, inflammation, impaired quality control, and altered cellular bioenergetics. We evaluate mitochondrial-associated biomarkers for disease severity, progression, and patient stratification, while considering their limited specificity and susceptibility to confounding by aging and comorbidities. We also assess the limitations of broad-spectrum antioxidant strategies and examine mitochondrial-targeted antioxidants and metabolic modulators, such as SS-31, MitoQ, and metformin. In addition, the review examines emerging mitochondrial stress pathways, including OMA1-DELE1-HRI signaling, while emphasizing that their direct involvement in chronic obstructive pulmonary disease remains unestablished. Altogether, the evidence available supports mitochondrial biology as a complementary area of investigation within the broader inflammatory, structural, and metabolic heterogeneity of chronic obstructive pulmonary disease, while our review reveals that substantial mechanistic and clinical validation remains necessary.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.59249/uvmv3274
- Canonical
- link ↗
- Fetched
- 2026-11-14 MST
Cite this
APA
Bhat, R., Dunne, L.B., Miles, S., Kazi, A., Siddiqui, D., Warriach, M.N., Ofoegbu, C.T., & Vellani, Z. (2026). Mitochondrial Dysfunction and Bioenergetics in Chronic Obstructive Pulmonary Disease: Mechanisms, Biomarkers, and Therapeutic Opportunities. <em>The Yale Journal of Biology and Medicine</em>. https://doi.org/10.59249/uvmv3274
Vancouver
Bhat R, Dunne LB, Miles S, Kazi A, Siddiqui D, Warriach MN, et al. Mitochondrial Dysfunction and Bioenergetics in Chronic Obstructive Pulmonary Disease: Mechanisms, Biomarkers, and Therapeutic Opportunities. The Yale Journal of Biology and Medicine. 2026. doi:10.59249/uvmv3274.
BibTeX
@article{rishit2026Mitoch,
title = {Mitochondrial Dysfunction and Bioenergetics in Chronic Obstructive Pulmonary Disease: Mechanisms, Biomarkers, and Therapeutic Opportunities},
author = {Rishit Bhat and Liam B. Dunne and Sophia Miles and Ahmad Kazi and Daniyal Siddiqui and Mutahhar N. Warriach and Chibudom T. Ofoegbu and Zaid Vellani},
journal = {The Yale Journal of Biology and Medicine},
year = {2026},
doi = {10.59249/uvmv3274},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
The Yale journal of biology and medicine 2026
Open access · OA
Mitochondrial Dysfunction and Bioenergetics in Chronic Obstructive Pulmonary Disease: Mechanisms, Biomarkers, and Therapeutic Opportunities.
Frontiers in immunology
Open access · OA
The role of the gut–lung axis in persistent inflammation and disease progression in chronic obstructive pulmonary disease: mechanistic evidence and therapeutic implications
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2026
Open access · OA
Immunosenescence as a modifiable driver of neurodegenerative diseases: Pathways and multidimensional emerging strategies for Alzheimer's and Parkinson's diseases.
International Journal of Molecular Sciences 2026
Open access · CC-BY
Dietary Polyphenols in Aging: A Systems-Level Perspective on Mitochondrial Quality Control and Microbiome Interactions
International journal of molecular sciences 2026
Open access · OA
Dietary Polyphenols in Aging: A Systems-Level Perspective on Mitochondrial Quality Control and Microbiome Interactions.
Hepatology Communications 2025
Open access · CC-BY